Mortality and Associated Factors in Patients with COVID-19: Cross-Sectional Study
- PMID: 36679916
- PMCID: PMC9863925
- DOI: 10.3390/vaccines11010071
Mortality and Associated Factors in Patients with COVID-19: Cross-Sectional Study
Abstract
The novel virus severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is highly virulent and causes coronavirus disease 2019 (COVID-19), resulting in high morbidity and mortality mainly associated with pulmonary complications. Because this virus is highly transmissible, it was quickly spread globally, resulting in COVID-19 being declared as a pandemic. This study aimed to analyze the prevalence of mortality and the factors related to mortality due to COVID-19 in patients with severe acute respiratory syndrome (SARS) at a university hospital in the Central—West region of Brazil. This retrospective cross-sectional study was based on an analysis of the medical records of patients with SARS aged >18 years and admitted to an intensive care unit due to COVID-19 with the requirement of invasive mechanical ventilation. Hospital death was considered as an outcome variable in this study. Moreover, demographic and lifestyle-related variables as well as the therapeutic measures used during the hospital stay were recorded and correlated with the death outcome. After excluding 188 medical records, 397 were analyzed. Most of the participants were men (59.7%), and the mortality rate in patients with SARS due to COVID-19 was 46.1%. Multiple regression analysis indicated that the independent factors associated with mortality in patients with SARS due to COVID-19 were the age of >60 years (p < 0.001) and the use of azithromycin (p = 0.012). Protective factors for mortality were considered as not having the following diseases: hyperthyroidism, asthma, hepatic inheritance, and not being a smoker. The mortality rate in patients with SARS due to COVID-19 was associated with older age and the use of azithromycin.
Keywords: COVID-19; critical care; mortality; respiratory distress syndrome.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.Lancet Reg Health Am. 2022 Apr;8:100177. doi: 10.1016/j.lana.2021.100177. Epub 2022 Jan 7. Lancet Reg Health Am. 2022. PMID: 35018359 Free PMC article.
-
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16. Am J Emerg Med. 2021. PMID: 33046317 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
Cited by
-
Thyroid dysfunction in the wake of Omicron: understanding its role in COVID-19 severity and mortality.Front Endocrinol (Lausanne). 2024 Jul 16;15:1412320. doi: 10.3389/fendo.2024.1412320. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39081794 Free PMC article.
-
Significant association between asthma and a lower risk of mortality among COVID-19 patients in Spain: A meta-analysis.Qatar Med J. 2024 Jul 4;2024(3):34. doi: 10.5339/qmj.2024.34. eCollection 2024. Qatar Med J. 2024. PMID: 39040991 Free PMC article. Review.
-
Clinical-laboratory characteristics predictive of COVID-19 severity: a prospective hospital cohort, in Pernambuco, Northeast Brazil.Braz J Microbiol. 2024 Sep;55(3):2643-2654. doi: 10.1007/s42770-024-01382-2. Epub 2024 Jul 2. Braz J Microbiol. 2024. PMID: 38955981 Free PMC article.
-
Necrotizing Skin and Soft Tissue Infection after Gluteal Augmentation in a Perioperatively Asymptomatic COVID-19 Patient-Complications of the Post-Lockdown Era? A Case Report.Medicina (Kaunas). 2023 May 10;59(5):914. doi: 10.3390/medicina59050914. Medicina (Kaunas). 2023. PMID: 37241146 Free PMC article.
-
COVID-19 case fatality ratio and survival among hospitalized adults in Goiás, 2020: a cohort study.Epidemiol Serv Saude. 2025 May 23;34:e20240053. doi: 10.1590/S2237-96222025v34e20240053.en. eCollection 2025. Epidemiol Serv Saude. 2025. PMID: 40435037 Free PMC article.
References
-
- Grasselli G., Greco M., Zanella A., Albano G., Antonelli M., Bellani G., Bonanomi E., Cabrini L., Carlesso E., Castelli G., et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180:1345–1355. doi: 10.1001/jamainternmed.2020.3539. - DOI - PMC - PubMed
-
- Ferrara N., Campobasso C.P., Cocozza S., Conti V., Davinelli S., Costantino M., Cannavo A., Rengo G., Filippelli A., Corbi G. Relationship between COVID-19 Mortality, Hospital Beds, and Primary Care by Italian Regions: A Lesson for the Future. J. Clin. Med. 2022;11:4196. doi: 10.3390/jcm11144196. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous